When: Tuesday, February 18, 2020, from 1:30 to 3 pm ET
Registration: Register for Medicare Learning Network events.
- Presentation (PDF)
- Audio recording and transcript: Available approximately 2 weeks after the event
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) outlines national strategies to help address opioid misuse. As part of Section 6084, CMS must evaluate the extent to which Medicare Advantage plans offer supplemental benefits to treat or prevent substance use disorders (SUDs) not otherwise covered under traditional Medicare, including how clinicians are impacted by the availability of supplemental benefits used to treat SUDs.
CMS wants to collect your feedback on:
- What supplemental benefits do you use now to treat your Medicare Advantage patients with SUDs?
- Are there any challenges associated with accessing or using these supplemental benefits to treat patients, and if so, what are they?
- What benefits currently exist in the medical community for treatment of SUDs that you would like to see offered by your Medicare Advantage plan in the future?
Target Audience: Clinicians and state and national associations that represent health care providers